Intended for healthcare professionals


NHS to rollout continuous glucose monitors for all patients with type 1 diabetes

BMJ 2022; 378 doi: (Published 02 August 2022) Cite this as: BMJ 2022;378:o1935
  1. Zainab Hussain
  1. The BMJ

All patients with type 1 diabetes in England will now be eligible for continuous glucose monitors, the NHS has announced.

NHS England said it had secured a deal with the manufacturer Dexcom to make continuous glucose monitors available on prescription at a similar price to flash monitor counterparts.

The devices, called Dexcom ONE Real Time-Continuous Glucose Monitoring, can be worn on the arm for up to 10 days. They use a sensor no larger than a bottle cap to measure glucose levels from under the skin, sending information to a mobile app for patients to track without having …

View Full Text

Log in

Log in through your institution


* For online subscription